Further analysis of multiple independent gene expression data sets from patients with known clinical outcomes has revealed that activation of the HSF1 cancer program is also associated with reduced survival in colon and lung cancer, and, importantly, much more significantly than any individual, or even a panel of, HSP transcript(s) [65]. The gene discussed is HSF1; the disease is cancer.